HomeNewsPodcastIn The News podcast | Yes Bank finds new investors; SpiceJet quarantines coronavirus suspect; education abroad gets costlier

In The News podcast | Yes Bank finds new investors; SpiceJet quarantines coronavirus suspect; education abroad gets costlier

Moneycontrol's Anvita Bansal gets in conversation with Siddhesh Raut, Shraddha Sharma, Nachiket Deuskar and M Saraswathy from the newsroom to find out the top stories of the day.

February 14, 2020 / 18:45 IST
Story continues below Advertisement

Moneycontrol's Anvita Bansal gets in conversation with Siddhesh Raut, Shraddha Sharma, Nachiket Deuskar and M Saraswathy from the newsroom to find out the top stories of the day.

In the February 13 edition of In The News podcast, host Anvita Bansal gets in conversation with Siddhesh Raut, Shraddha Sharma, Nachiket Deuskar and M Saraswathy from the Moneycontrol newsroom to find out the latest updates from India and around the world.

Story continues below Advertisement

First up, she talks to Raut about Yes Bank delaying Q3 results as the lender is in conversation with prominent investors to raise capital.

Next, Sharma gives updates on the coronavirus outbreak after a SpiceJet passenger was suspected of the infection and was quarantined at Delhi Airport.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show